Related Experiment Videos
Insights into the pathophysiology of unstable coronary artery disease
S D Kristensen1, H B Ravn, E Falk
1Department of Cardiology and Institute of Experimental Clinical Research, Skejby Hospital, Aarhus N, Denmark.
Insights
Coronary plaque rupture, not just blockage, causes heart attacks. Vulnerable plaques, defined by their composition and inflammation, are key culprits. Identifying and treating these dangerous plaques is crucial for preventing sudden death.
Area of Science:
- Cardiovascular Medicine
- Pathology
- Biochemistry
Background:
- Coronary atherosclerosis typically progresses without symptoms.
- Plaque disruption, leading to thrombosis, is a common complication.
- Plaque rupture can result in severe clinical events like myocardial infarction and sudden death.
Purpose of the Study:
- To analyze the determinants of plaque vulnerability and disruption in coronary atherosclerosis.
- To understand the role of plaque composition and inflammation in rupture risk.
- To highlight the importance of identifying and treating vulnerable plaques and optimizing antithrombotic therapy.
Main Methods:
- Review of existing literature on coronary plaque composition and rupture.
- Analysis of factors influencing plaque vulnerability (lipid core, fibrous cap, inflammation).
- Evaluation of extrinsic factors (rupture triggers) and their interaction with plaque characteristics.
Main Results:
- Plaque vulnerability is primarily determined by its composition (lipid core size, fibrous cap thickness, inflammation) rather than stenosis severity.
- Both intrinsic plaque vulnerability and extrinsic rupture triggers contribute to plaque disruption.
- The thrombotic response depends on platelet reactivity and the balance of coagulation and fibrinolysis.
Conclusions:
- Vulnerable plaques, characterized by specific compositional and inflammatory features, pose a significant risk for rupture and thrombosis.
- Effective prevention and treatment strategies require identifying these dangerous plaques and optimizing antithrombotic therapies.
- Further research into the identification and management of vulnerable plaques is essential to reduce coronary thrombosis-related mortality.
Abstract:
Coronary atherosclerosis without thrombosis is, in general, a benign disease. However, plaque disruption, or fissuring, with superimposed thrombosis, frequently complicates the course of coronary atherosclerosis. Small ruptures often remain clinically silent, whereas more extensive plaque rupture may cause the development of unstable angina, myocardial infarction, and sudden death. The risk of plaque disruption depends more on plaque type (composition) than on plaque size and stenosis severity. Major determinants of a plaque's vulnerability to rupture are: the size and consistency of the lipid-rich atheromatous core; the thickness of the fibrous cap covering the core; and ongoing inflammation and repair within the cap. Both plaque vulnerability (intrinsic disease) and rupture triggers (extrinsic forces) are important for plaque disruption. The former predisposes the plaque to rupture whereas the latter may precipitate it. The resultant thrombotic response, which is important for the clinical presentation and outcome, is portly determined by the reactivity of the circulating platelets and the balance between the fibrinolytic and coagulation systems. New ways of identification and treatment of the dangerous vulnerable plaques responsible for infarction and death, and optimization of antithrombotic treatment, are highly warranted in order to prevent and treat life-threatening coronary thrombosis.